SEATTLE — Approximately 15% of the U.S. population - 40 million Americans - suffer from Migraine, a disabling disease characterized by attacks with pulsating headaches that can last anywhere from 4 to ...

Aprecia's Spritam tablets, quickly dissolvable in liquid--Courtesy of Aprecia The FDA on Monday approved Aprecia Pharmaceuticals' Spritam, which is the first 3-D printed product designed for use in ...

If you purchase an independently reviewed product or service through a link on our website, Rolling Stone may receive an affiliate commission. I don’t know if anybody has told you this or not, but ...

SOMERSET, NJ, February 15, 2011 - Catalent Pharma Solutions, the world's leading provider of advanced oral drug delivery technologies and solutions, announced that it has entered into a license ...